GSK is prioritizing development of its hepatitis B treatment bepirovirsen as the pharma ends work on another potential ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

Current antiviral treatment for chronic hepatitis B is effective ... On one hand, future drugs should have improved tolerability and durability. Treatment that can increase the chance of HBsAg ...

The viral illness kills more people in the city than HIV, but antiviral medications may be helping cut its transmission.

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

[1] Since 1992, the inclusion of hepatitis B vaccination has been recommended ... which is largely related to the abuse of parenteral drugs and/or exposure to other risk factors such as unsafe ...

Collaboration with South Korean university advocates early antiviral treatment for hepatitis B | Feb. 5, 2025 13:09 ...

REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Bluejay Therapeutics, a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...